Jennifer Kubin, APRN
Psychiatric/Mental Health · Baldwin City, KSNPI 1962196360
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $21,490 of the $25,900 with a category attached, or 83.0%. Johnson & Johnson accounts for 99.5% of it on its own, with 2 other manufacturers making up the rest. Among psychiatric/mental health clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $488.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$26K
- Janssen Scientific Affairs, LLC$100
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$18
What the payments were for
- Speaking & faculty fees$21,49083%
- Travel & lodging$2,95611%
- Food & beverage$1,4546%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 51 | $25,782 |
| Janssen Scientific Affairs, LLC | 1 | $100 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$25,220
How this compares
$25,900 in reported general payments places this provider in the 95th percentile of 404 psychiatric/mental health providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atomoxetine Hcl | 24 | $3,466 |
| Lithium Carbonate ErLithium Carbonate | 83 | $721 |
| Duloxetine Hcl | 38 | $612 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 21 | $519 |
| Bupropion XlBupropion Hcl | 25 | $455 |
| Eszopiclone | 17 | $235 |
| Lamotrigine | 19 | $143 |
| Lithium Carbonate | 14 | $138 |
| Trazodone Hcl | 18 | $75 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Baldwin City
- Eric ThomasonPittsburg$333K
- Belinda BagbyHutchinson$39K
- Hayley KnappWichita$31K
- Uyen DinhPittsburg$20K
- Louise MuhoziKansas City$14K
- Theresa MuellerOverland Park$14K
- Shiney ZchariaOlathe$14K
- Deborah MurphyWichita$13K
- Marijen AgaShawnee$13K
- Anucia JosephMission$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.